Vivos Inc (RDGL)

[doccjc]

A couple weeks away(maybe sooner) from some huge updates regarding India trial results.
Initial 5 patients were dosed in the second half of December, so the 90 day results are expected in the second half of March (pending a timely return for follow up visits by the patients).

Vivos Inc. proudly announces the initiation of its first human clinical trial for RadioGel® Precision Radionuclide Therapy™ in India. Visit our websites https://t.co/FfgSTxpyrZ and https://t.co/CRzVE4sr7t to see full press release, subscribers check your inbox $RDGL pic.twitter.com/m3uHRhSrBx

— Vivos Inc. (@VivosIncUSA) December 23, 2024

The 30 day data from the second set of patients treated is also expected this month since they were treated sometime in February, (making the assumption that they were dosed when the company said the trial initiated in the Feb 13th update.

Update on the India Trials - Thursday, Feb 13 in Bangalore, India patients were treated using RadioGel® Precision Radionuclide Therapy™. We will update with more details as they become available. Subscribe to our email list at https://t.co/tgqyQwBh65 $RDGL pic.twitter.com/0LATiYbWVM

— RadioGel® (@RadioGel) February 13, 2025

Should be a very busy month for updates and possibly PR's